Acute Liver Failure and Related Syndromes

Textbook of Hepatology: From Basic Science to Clinical Practice, Third Edition

Volumn , Issue , 2008, Pages 1289-1312

  Durand, François ^a,b,c   Bernuau, Jacques ^c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c BEAUJON HOSPITAL   (France)

Author keywords

Alanine aminotransferase; Drug reactions; Encephalopathy; Liver cell damage; Liver failure

Indexed keywords

EID: 84889471964     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470691861.ch15     Document Type: Chapter

References (111)

1. Bernuau J (2004) Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain. J Hepatol 41, 152-155.
2. Polson J, Lee WM (2005) AASLD position paper: the management of acute liver failure. Hepatology 41, 1179-1197.
3. Trey CDC (1970) The management of fulminant hepatic failure. Prog Liver Dis 3, 282-298.
4. Navasa M, Garcia-Pagan JC, Bosch J et al. (1992) Portal hypertension in acute liver failure. Gut 33, 965-968.
5. Bhatia V, Batra Y, Acharya SK (2004) Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure-a controlled clinical trial. J Hepatol 41, 89-96.
6. Schiodt FV, Balko J, Schilsky M et al. (2003) Thrombopoietin in acute liver failure. Hepatology 37, 558-561.
7. Bernal W, Donaldson N, Wyncoll D et al. (2002) Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 359, 558-563.
8. Vaquero J, Polson J, Chung C et al. (2003) Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology 125, 755-764.
9. Riordan SM, Williams R (2003) Mechanisms of hepatocyte injury, multiorgan failure, and prognostic criteria in acute liver failure. Semin Liver Dis 23, 203-215.
10. Pham BN, Mosnier JF, Durand F et al. (1995) Immunostaining for membrane attack complex of complement is related to cell necrosis in fulminant and acute hepatitis. Gastroenterology 108, 495-504.
11. Clemmesen JO, Kondrup J, Ott P (2000) Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 118, 1131-1139.
12. Blei AT, Larsen FS (1999) Pathophysiology of cerebral edema in fulminant hepatic failure. J Hepatol 31, 771-776.
13. Butterworth RF (2003) Molecular neurobiology of acute liver failure. Semin Liver Dis 23, 251-258.
14. Larsen FS, Ejlersen E, Hansen BA et al. (1995) Functional loss of cerebral blood flow autoregulation in patients with fulminant hepatic failure. J Hepatol 23, 212-217.
15. Lee WM (2004) Acetaminophen and the US Acute Liver Failure Study Group: lowering the risks of hepatic failure. Hepatology 40, 6-9.
16. Bernal W (2003) Changing patterns of causation and the use of transplantation in the United Kingdom. Semin Liver Dis 23, 227-337.
17. Ostapowicz G, Fontana RJ, Schiodt FV et al. (2002) Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 137, 947-954.
18. Schiodt FV, Rochling FA, Casey DL et al. (1997) Acetaminophen toxicity in an urban county hospital. N Engl J Med 337, 1112-1117.
19. McCormick PA, Treanor D, McCormack G et al. (2003) Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema. J Hepatol 39, 547-551.
20. O'Grady JG, Schalm SW, Williams R (1993) Acute liver failure: redefining the syndromes. Lancet 342, 273-275.
21. Vento S, Garofano T, Renzini C et al. (1998) Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 338, 286-290.
22. Bernuau J, Goudeau A, Poynard T et al. (1986) Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology 6, 648-651.
23. Sato S, Suzuki K, Akahane Y et al. (1995) Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med 122, 241-248.
24. Garfein RS, Bower WA, Loney CM et al. (2004) Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B. Hepatology 40, 865-873.
25. Lok AS, Liang RH, Chiu EK et al. (1991) Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 100, 182-188.
26. Mas A, Buti M, Esteban R et al. (1990) Hepatitis B virus and hepatitis D virus replication in HBsAg-positive fulminant hepatitis. Hepatology 11, 1062-1065.
27. Wu JC, Choo KB, Chen CM et al. (1995) Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 346, 939-941.
28. Hamid SS, Jafri SM, Khan H et al. (1996) Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis? J Hepatol 25, 20-27.
29. Glorioso DV, Molloy PJ, Van Thiel DH et al. (1996) Successful empiric treatment of HSV hepatitis in pregnancy. Case report and review of the literature. Dig Dis Sci 41, 1273-1275.
30. Posthuma EF, Westendorp RG, van der Sluys Veer A et al. (1995) Fatal infectious mononucleosis: a severe complication in the treatment of Crohn's disease with azathioprine. Gut 36, 311-313.
31. Sobue R, Miyazaki H, Okamoto M et al. (1991) Fulminant hepatitis in primary human herpesvirus-6 infection. N Engl J Med 324, 1290.
32. Langnas AN, Markin RS, Cattral MS et al. (1995) Parvovirus B19 as a possible causative agent of fulminant liver failure and associated aplastic anemia. Hepatology 22, 1661-1665.
33. Elisaf M, Stefanaki S, Repanti M et al. (1993) Liver involvement in hemorrhagic fever with renal syndrome. J Clin Gastroenterol 17, 33-37.
34. Mas A (2005) Mushrooms, amatoxins and the liver. J Hepatol 42, 166-169.
35. Ganzert M, Felgenhauer N, Zilker T (2005) Indication of liver transplantation following amatoxin intoxication. J Hepatol 42, 202-209.
36. Babany G, Bernuau J, Cailleux A et al. (1991) Severe monochlorobenzene-induced liver cell necrosis. Gastroenterology 101, 1734-1736.
37. Larrey D, Vial T, Pauwels A et al. (1992) Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 117, 129-132.
38. Ellis AJ, Wendon JA, Portmann B et al. (1996) Acute liver damage and ecstasy ingestion. Gut 38, 454-458.
39. Berson A, Gervais A, Cazals D et al. (2001) Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol 34, 346-350.
40. Lee WM (2003) Acute liver failure in the United States. Semin Liver Dis 23, 217-226.
41. Durand F, Jebrak G, Pessayre D et al. (1996) Hepatotoxicity of antitubercular treatments. Rationale for monitoring liver status. Drug Safety 15, 394-405.
42. Durand F, Bernuau J, Pessayre D et al. (1995) Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid. Hepatology 21, 929-932.
43. Russo MW, Galanko JA, Shrestha R et al. (2004) Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl 10, 1018-1023.
44. Paterson D, Kerlin P, Walker N et al. (1992) Piroxicam induced submassive necrosis of the liver. Gut 33, 1436-1438.
45. McKenzie R, Fried MW, Sallie R et al. (1995) Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 333, 1099-1105.
46. Durand F, Samuel D, Bernuau J et al. (1992) Fipexide-induced fulminant hepatitis. Report of three cases with emergency liver transplantation. J Hepatol 15, 144-146.
47. Mathurin P, Durand F, Ganne N et al. (1995) Ischemic hepatitis due to obstructive sleep apnea. Gastroenterology 109, 1682-1684.
48. Henrion J, Minette P, Colin L et al. (1999) Hypoxic hepatitis caused by acute exacerbation of chronic respiratory failure: a case-controlled, hemodynamic study of 17 consecutive cases. Hepatology 29, 427-433.
49. Saissy JM (1996) Liver transplantation in a case of fulminant liver failure after exertion. Intens Care Med 22, 831.
50. Hadad E, Ben-Ari Z, Heled Y et al. (2004) Liver transplantation in exertional heat stroke: a medical dilemma. Intens Care Med 30, 1474-1478.
51. Durand F, Bernuau J, Giostra E et al. (2001) Wilson's disease with severe hepatic insufficiency: beneficial effects of early administration of D-penicillamine. Gut 48, 849-852.
52. Stampfl DA, Munoz SJ, Moritz MJ et al. (1990) Heterotopic liver transplantation for fulminant Wilson's disease. Gastroenterology 99, 1834-1836.
53. Rowbotham D, Wendon J, Williams R (1998) Acute liver failure secondary to hepatic infiltration: a single centre experience of 18 cases. Gut 42, 576-580.
54. Te HS, Schiano TD, Kahaleh M et al. (1999) Fulminant hepatic failure secondary to malignant melanoma: case report and review of the literature. Am J Gastroenterol 94, 262-266.
55. Phillips MJ, Blendis LM, Poucell S et al. (1991) Syncytial giant-cell hepatitis. Sporadic hepatitis with distinctive pathological features, a severe clinical course, and paramyxoviral features. N Engl J Med 324, 455-460.
56. Durand F, Degott C, Sauvanet A et al. (1997) Subfulminant syncytial giant cell hepatitis: recurrence after liver transplantation treated with ribavirin. J Hepatol 26, 722-726.
57. Ockner SA, Brunt EM, Cohn SM et al. (1990) Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation. Hepatology 11, 59-64.
58. Sibai B, Dekker G, Kupferminc M (2005) Pre-eclampsia. Lancet 365, 785-799.
59. Casteels-Van Daele M, Wouters C, Van Geet C et al. (2002) Reye's syndrome revisited. Outdated concept of Reye's syndrome was used. BMJ 324, 546.
60. Mutimer D, Shaw J, Neuberger J et al. (1995) Failure to incriminate hepatitis B, hepatitis C, and hepatitis E viruses in the aetiology of fulminant non-A non-B hepatitis. Gut 36, 433-436.
61. O'Grady JG, Alexander GJ, Hayllar KM et al. (1989) Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 97, 439-445.
62. Takahashi Y, Kumada H, Shimizu M et al. (1994) A multicenter study on the prognosis of fulminant viral hepatitis: early prediction for liver transplantation. Hepatology 19, 1065-1071.
63. Acharya SK, Dasarathy S, Kumer TL et al. (1996) Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology 23, 1448-1455.
64. Izumi S, Langley PG, Wendon J et al. (1996) Coagulation factor V levels as a prognostic indicator in fulminant hepatic failure. Hepatology 23, 1507-1511.
65. Baquerizo A, Anselmo D, Shackleton C et al. (2003) Phosphorus as an early predictive factor in patients with acute liver failure. Transplantation 75, 2007-2014.
66. Dabos KJ, Newsome PN, Parkinson JA et al. (2004) Biochemical prognostic markers of outcome in non-paracetamol-induced fulminant hepatic failure. Transplantation 77, 200-205.
67. Schmidt LE, Dalhoff K (2005) Alpha-fetoprotein is a predictor of outcome in acetaminophen-induced liver injury. Hepatology 41, 26-31.
68. Schiodt FV, Rossaro L, Stravitz RT et al. (2005) Gc-globulin and prognosis in acute liver failure. Liver Transpl 11, 1223-1227.
69. Saibara T, Onishi S, Maeda T et al. (1992) Arterial blood ketone body ratio as a possible indicator for predicting fulminant hepatitis in patients with acute hepatitis. Liver 12, 392-396.
70. Shakil AO, Kramer D, Mazariegos GV et al. (2000) Acute liver failure: clinical features, outcome analysis, and applicability of prognostic criteria. Liver Transpl 6, 163-169.
71. Bailey B, Amre DK, Gaudreault P (2003) Fulminant hepatic failure secondary to acetaminophen poisoning: a systematic review and meta-analysis of prognostic criteria determining the need for liver transplantation. Crit Care Med 31, 299-305.
72. Wiesner RH (2004) MELD/PELD and the allocation of deceased donor livers for status 1 recipients with acute fulminant hepatic failure, primary nonfunction, hepatic artery thrombosis, and acute Wilson's disease. Liver Transpl 10, S17-22.
73. Poland GA, Jacobson RM (2004) Clinical practice: prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 351, 2832-2838.
74. Shim M, Khaykis I, Park J et al. (2005) Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. Hepatology 42, 688-695.
75. Langley PG, Hughes RD, Forbes A et al. (1993) Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol 17, 326-331.
76. Harrison PM, Wendon JA, Gimson AE et al. (1991) Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure. N Engl J Med 324, 1852-1857.
77. Shawcross DL, Davies NA, Mookerjee RP et al. (2004) Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology 39, 471-475.
78. Blei AT (2005) Monitoring cerebral blood flow: a useful clinical tool in acute liver failure? Liver Transpl 11, 1320-1322.
79. Blei AT, Olafsson S, Webster S et al. (1993) Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 341, 157-158.
80. White H, Baker A (2002) Continuous jugular venous oximetry in the neurointensive care unit-a brief review. Can J Anaesth 49, 623-629.
81. Helmke K, Burdelski M, Hansen HC (2000) Detection and monitoring of intracranial pressure dysregulation in liver failure by ultrasound. Transplantation 70, 392-395.
82. Madl C, Grimm G, Ferenci P et al. (1994) Serial recording of sensory evoked potentials: a noninvasive prognostic indicator in fulminant liver failure. Hepatology 20, 1487-1494.
83. Strauss GI, Christiansen M, Moller K et al. (2001) S-100b and neuron-specific enolase in patients with fulminant hepatic failure. Liver Transpl 7, 964-970.
84. Murphy N, Auzinger G, Bernel W et al. (2004) The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 39, 464-470.
85. Vaquero J, Blei AT (2004) Cooling the patient with acute liver failure. Gastroenterology 127, 1626-1629.
86. Jalan R, Olde Damink SW, Deutz NE et al. (2004) Moderate hypothermia in patients with acute liver failure and uncontrolled intracranial hypertension. Gastroenterology 127, 1338-1346.
87. Ellis AJ, Wendon JA, Williams R (2000) Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 32, 536-541.
88. Schmidt LE, Wang LP, Hansen BA et al. (2003) Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial. Liver Transpl 9, 290-297.
89. Demetriou AA, Brown RS, Jr, Busuttil RW et al. (2004) Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 239, 660-667; discussion 667-670.
90. Ellis AJ, Hughes RD, Wendon JA et al. (1996) Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24, 1446-1451.
91. Kjaergard LL, Liu J, Als-Nielsen B et al. (2003) Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA 289, 217-222.
92. Chari RS, Collins BH, Magee JC et al. (1994) Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. N Engl J Med 331, 234-237.
93. Pauwels A, Mostefa-Kara N, Florent C et al. (1993) Emergency liver transplantation for acute liver failure. Evaluation of London and Clichy criteria. J Hepatol 17, 124-127.
94. Blei AT (2005) Selection for acute liver failure: have we got it right? Liver Transpl 11, S30-34.
95. Belghiti J, Noun R, Sauvanet A et al. (1995) Transplantation for fulminant and subfulminant hepatic failure with preservation of portal and caval flow. Br J Surg 82, 986-989.
96. Bismuth H, Samuel D, Castaing D et al. (1995) Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience. Ann Surg 222, 109-119.
97. Chenard-Neu MP, Boudjema K, Bernuau J et al. (1996) Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure-a multicenter European study. Hepatology 23, 1119-1127.
98. Durand F, Belghiti J, Handra-Luca A et al. (2002) Auxiliary liver transplantation for fulminant hepatitis B: results from a series of six patients with special emphasis on regeneration and recurrence of hepatitis B. Liver Transpl 8, 701-707.
99. Bernuau J, Rueff B, Benhamou JP (1986) Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 6, 97-106.
100. Devlin J, Williams R (1996) Transplantation for fulminant hepatic failure: comparing tacrolimus versus cyclosporine for immunosuppression and the outcome in elective transplants. European FK506 Liver Study Group. Transplantation 62, 1251-1255.
101. Vickers C, Neuberger J, Buckels J et al. (1988) Transplantation of the liver in adults and children with fulminant hepatic failure. J Hepatol 7, 143-150.
102. Iwatsuki S, Stieber AC, Marsh JW et al. (1989) Liver transplantation for fulminant hepatic failure. Transplant Proc 21, 2431-2434.
103. Gallinger S, Greig PD, Levy G et al. (1989) Liver transplantation for acute and subacute fulminant hepatic failure. Transplant Proc 21, 2435-2438.
104. Emond JC, Aran PP, Whitington PF et al. (1989) Liver transplantation in the management of fulminant hepatic failure. Gastroenterology 96, 1583-1588.
105. Farmer DG, Anselmo DM, Ghobrial RM et al. (2003) Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 237, 666-675; discussion 675-676.
106. Washburn WK, Bradley J, Cosimi AB et al. (1996) A regional experience with emergency liver transplantation. Transplantation 61, 235-239.
107. Bismuth H, Azoulay D, Samuel D et al. (1996) Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience. Ann Surg 224, 712-724; discussion 724-726.
108. Pereira SP, McCarthy M, Ellis AJ et al. (1997) Auxiliary partial orthotopic liver transplantation for acute liver failure. J Hepatol 26, 1010-1017.
109. Sudan DL, Langnas AN, Shaw BW, Jr (1997) Long-term follow-up of auxiliary liver transplantation for fulminant hepatic failure. Transplant Proc 29, 485-486.
110. Uemoto S, Inomata Y, Sakurai T et al. (2000) Living donor liver transplantation for fulminant hepatic failure. Transplantation 70, 152-157.
111. Miwa S, Hashikura Y, Mita A et al. (1999) Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure. Hepatology 30, 1521-1526.